Tuesday, March 13, 2007

 

Noven Receives $25 Million Daytrana(TM) Sales Milestone



Genetic Engineering News - Daytrana(TM), developed and manufactured by Noven, is the first and only transdermal medication before using Daytrana(TM) if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness, or hopelessness) or bipolar
Source: www.genengnews.com


Click here for more information about beck depression inventory beck depression inventory





<< Home

This page is powered by Blogger. Isn't yours?